Dupilumab (DPL) Efficacy in Patients With Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) with/without Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease (NSAID-ERD): SINUS-24, SINUS-52 Trials J. Mullol (Barcelona, Spain), T. Laidlaw (Boston, United States of America), N. Amin (Tarrytown, United States of America), C. Bachert (Ghent (Belgium) and Stockholm, Sweden), J. Han (Norfolk, United States of America), P. Hellings (Leuven, Belgium), G. Canonica (Milan, Italy), S. Cho (Tampa, United States of America), J. Maspero (Buenos Aires, Argentina), M. Desrosiers (Montreal, Canada), C. Hopkins (London, United Kingdom), P. Paggiaro (Pisa, Italy), M. Zhang (Bridgewater, United States of America), X. Lu (Bridgewater, United States of America), N. Patel (Bridgewater, United States of America), N. Graham (Tarrytown, United States of America), H. Staudinger (Bridgewater, United States of America), L. Mannent (Chilly-Mazarin, France)
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Disease area: Airway diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Mullol (Barcelona, Spain), T. Laidlaw (Boston, United States of America), N. Amin (Tarrytown, United States of America), C. Bachert (Ghent (Belgium) and Stockholm, Sweden), J. Han (Norfolk, United States of America), P. Hellings (Leuven, Belgium), G. Canonica (Milan, Italy), S. Cho (Tampa, United States of America), J. Maspero (Buenos Aires, Argentina), M. Desrosiers (Montreal, Canada), C. Hopkins (London, United Kingdom), P. Paggiaro (Pisa, Italy), M. Zhang (Bridgewater, United States of America), X. Lu (Bridgewater, United States of America), N. Patel (Bridgewater, United States of America), N. Graham (Tarrytown, United States of America), H. Staudinger (Bridgewater, United States of America), L. Mannent (Chilly-Mazarin, France). Dupilumab (DPL) Efficacy in Patients With Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) with/without Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease (NSAID-ERD): SINUS-24, SINUS-52 Trials. 3783
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Dupilumab (DPL) Improves Upper and Lower Airway Outcomes in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) with Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease (NSAID-ERD): Pooled Results From SINUS-24, SINUS-52 Phase 3 Trials Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link? Source: International Congress 2014 – The assessment of comorbidities Year: 2014
LATE-BREAKING ABSTRACT: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: the SIRIUS study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014
Outcome of Nasal High Flow Nasal Oxygen Therapy (HFNO) in Acute Hypoxemic Respiratory Failure (AHRF) on an Acute Respiratory Care Unit (ARCU) Source: Sleep and Breathing Conference 2021 Year: 2021
Low Level of Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017
Comparison of three modalities of corticosteroids administration in chronic rhinosinusitis Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014
Evaluation of Asthma control and oral corticosteroids in Severe Asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021
Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018
The Effect Of An Active Exercise Program Combined With Chest Physiotherapy On Pain Severity,Posture, Respiratory Function And Quality Of Life In Patients With Chronic Obstructive Pulmonary Disease. Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019
Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study Source: Virtual Congress 2021 – Bronchiectasis Year: 2021
Late Breaking Abstract - First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB) Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations Year: 2018
Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
The Effect of Bronchial Thermoplasty on Lung Function in Severe Asthma Patients Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction Year: 2018
Clinically Meaningful Improvement in Total Rhinoconjunctivitis Score with Olopatadine/mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017
Risk of Haemophilus Influenzae Infection in Patients with Chronic Obstructive Pulmonary Disease Using Inhaled Corticosteroids: A Cohort Study of 23,789 Outpatients. Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021